Navigation Links
Bionovo Announces Third Quarter 2011 Highlights and Financial Results
Date:11/10/2011

s February 2011 public offering offset by clinical trial costs and operating expenses and capital expenditures to support the Menerba manufacturing facility in Hayward, California.

Conference CallBionovo will conduct a conference call and webcast to review the Company's financial results on Monday, November 14, 2011, at 1:30 PM PST, when further information on the non-clinical and clinical progress of Menerba will also be provided.

Interested parties can access the call by dialing 800-705-7067 or can listen via a live audio only webcast, which can be found at http://bionovo.com/investors/events. A replay of the call will be available by dialing 800-633-8284 (replay code 21544924) through November 18, 2011, and archived via audio webcast at http://bionovo.com/investors/events.

About Bionovo, Inc.Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California, and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking StatementsThis release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
2. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
3. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
4. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
6. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
7. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
8. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
9. Bionovo Announces 2010 Highlights and Year-End Financial Results
10. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
11. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 Research and Markets ... Market in Consumer Healthcare by Application, Sensor Type & ... - 2020" report to their offering. ... been an increasing momentum for consumer healthcare monitoring and ... The consumer healthcare will lessen the healthcare cost of ...
(Date:7/23/2014)... , July 23, 2014 NOT ... DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE ... LAWS OR REGULATIONS OF SUCH JURISDICTION. AbbVie (NYSE: ... results on Friday, July 25, 2014, before the market opens. ... earnings conference call at 8 a.m. Central time (9 a.m. ...
(Date:7/23/2014)... 2014 Research and Markets   ... Electrophysiology Ablation Catheters Market 2014-2018" report to ... Catheter ablation is a minimally ... electrical pathways from sections of the heart that ... arrhythmias). Cardiac arrhythmias can be of several types, ...
Breaking Medicine Technology:Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 2Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 3AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... Inc. (NASDAQ: DCTH ) today announced ... ISO 13485:2003 Certification—an internationally recognized quality standard designed ... necessary comprehensive quality management systems in place to ... in the European Union (EU). ISO 13485 Certification ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Devices Market Outlook to 2017- Glucose ... http://www.reportlinker.com/p0739469/South-and-Central-America-Diabetes-Care-Devices-Market-Outlook-to-2017--Glucose-Monitoring-and-Insulin-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ...
Cached Medicine Technology:Delcath's Ireland Operations Achieves ISO 13485 Certification 2Delcath's Ireland Operations Achieves ISO 13485 Certification 3South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 2South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 3South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 4South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 5South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 6South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 7South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 8South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 9
(Date:7/23/2014)... A scientist from the University of Exeter has ... for diagnosing a frequently fatal lung disease which ... and bone marrow transplant recipients. , The lateral-flow ... invasive pulmonary aspergillosis, a notoriously difficult to diagnose ... , Invasive aspergillosis is a ...
(Date:7/23/2014)... New York, New York (PRWEB) July 23, 2014 ... that the use of a power morcellator ( http://www.injurybeacon.com/power-morcellator/ ... uterine sarcoma and other cancers throughout a woman’s body, ... on July 22nd in the Journal of the American ... hysterectomy using a power morcellator at 500 U.S. hospitals ...
(Date:7/23/2014)... If past experience is anything to go by, ... get a lot more recognition for their contributions to ... allowing NPs to provide primary care offer nurses more ... relationships with physicians and administrators, compared with colleagues in ... School of Nursing, published in Health Care Management ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July ... American children and teens look in the mirror and ... reported Wednesday. "Being overweight or obese is associated ... high cholesterol and diabetes," said lead researcher Neda Sarafrazi, ... Control and Prevention,s National Center for Health Statistics. ...
(Date:7/23/2014)... The next episode of “Extreme Weight Loss” Season ... physically fit through childhood and adolescence. After becoming pregnant ... decision to give her son up for adoption. That ... and she punished herself by overeating, gaining nearly 200 ... approach to weight loss transformations, “Extreme Weight Loss” airs ...
Breaking Medicine News(10 mins):Health News:New device detects deadly lung disease 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:New York law offers nurses more recognition, responsibility 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 2Health News:Many Obese U.S. Kids Think They're Thinner Than They Are 3Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2
... Autism Speaks, the world,s largest autism science and ... top awards for "Autism Connects", the international student design ... competitors selected by a juried panel demonstrate creative technology ... better connect with the world around them, and allow ...
... News) -- People with allergies and asthma need to take ... Failure to remove contaminated materials and to reduce moisture and ... long-term health risks, according to the American College of Allergy, ... materials quickly lead to the growth of mold, a common ...
... (HealthDay News) -- Children have longer hospital stays if ... language skills, a U.S. study finds. The research, ... of Pediatrics & Adolescent Medicine , included almost 1,300 ... for treatment of infections requiring long-term antibiotics. Among ...
... 2011 The so-called "bad cholesterol" low-density lipoprotein ... shows a Texas A&M University study that casts new light on ... a researcher in the Department of Health and Kinesiology, says the ... health it has been made out to be in recent years ...
... today announced Horizon Pharma,s support of research awards ... through competition and recognition: AGA-Horizon ... $1,000 each to fellows who have submitted abstracts ... (DDW). , AGA-Horizon Pharma Student Abstract ...
... the University of North Carolina at Chapel Hill School of ... developing placenta, have given them the same properties of stem ... The scientific first opens the door for developing novel targeted ... TNBC, this is a highly recurrent tumor that spreads aggressively ...
Cached Medicine News:Health News:Autism Speaks and Core77 Magazine name winners of 'Autism Connects' design challenge 2Health News:Autism Speaks and Core77 Magazine name winners of 'Autism Connects' design challenge 3Health News:Autism Speaks and Core77 Magazine name winners of 'Autism Connects' design challenge 4Health News:Parents' Limited English May Prolong Child's Hospital Stay 2Health News:'Bad' cholesterol not as bad as people think, shows Texas A&M study 2Health News:Horizon Pharma supports fellows and students with AGA Abstract Prizes 2Health News:Normal stem cells made to look and act like cancer stem cells 2
Inquire...
... inspects your equipment upon arrival. Our technician then ... provides you with a thorough customer quote. We ... tight budget so well help you prioritize repairs. ... begins., , ISI uses only OEM or widely ...
... Konelab 20XT analyzer is the newest addition ... analyzers and reagents, designed to meet the ... specialty clinical laboratories. The Konelab 20XT analyzer ... 20 and yet improves on the throughput, ...
... The Shandon Coverplate is a plastic device that ... to be immunostained with a minimum amount of ... to fill the gap between the coverplate and ... until the next reagent is dispensed into the ...
Medicine Products: